TRMB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Trimble Inc (TRMB) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown positive financial performance in terms of net income and EPS growth, the current price trend and lack of significant positive catalysts suggest that waiting for a better entry point might be more prudent. The stock's technical indicators are neutral, and there are no strong trading signals or recent news to act as a catalyst for immediate growth. Analysts remain optimistic with Overweight ratings, but the stock's recent price decline and lack of significant momentum do not make it an ideal buy right now.
The MACD histogram is positive at 0.776 but contracting, suggesting weakening momentum. RSI is neutral at 62.335, indicating no overbought or oversold conditions. Moving averages are converging, showing no clear trend. Key support is at 65.68, and resistance is at 70.241. The stock is currently trading at $69.95, close to its resistance level, which limits immediate upside potential.
Analysts maintain Overweight ratings with price targets ranging from $88 to $
Financial performance shows strong YoY growth in net income (+73.61%) and EPS (+80.56%).
Gross margin improved to 69.18%, up 3.83% YoY.
Recent price decline of -0.67% in the regular market and -1.77% in pre-market trading.
Broader market sentiment is negative, with the S&P 500 down -1.32%.
Lack of recent news or event-driven catalysts.
Hedge funds and insiders show neutral trading activity, indicating no strong institutional or insider conviction.
In Q4 2025, revenue dropped by -1.38% YoY to $969.8M, but net income increased by 73.61% YoY to $156.6M. EPS grew by 80.56% YoY to 0.65, and gross margin improved by 3.83% YoY to 69.18%. This indicates strong profitability despite a slight decline in revenue.
Analysts are generally positive, with multiple Overweight ratings. Barclays recently raised its price target to $103, while Baird and JPMorgan lowered their targets to $90 and $88, respectively, citing solid execution and guidance. KeyBanc upgraded the stock to Overweight in December 2025, citing confidence in recurring revenue and EPS growth potential.
